|
1
|
All-trans retinoic acid in acute promyelocytic leukemia: long-term outcome and prognostic factor analysis from the North American Intergroup protocol.
|
Blood
|
2002
|
2.11
|
|
2
|
Pharmacogenetics of nevirapine-associated hepatotoxicity: an Adult AIDS Clinical Trials Group collaboration.
|
Clin Infect Dis
|
2006
|
1.44
|
|
3
|
Prevalence and persistence of cervical human papillomavirus infection in HIV-positive women initiating highly active antiretroviral therapy.
|
J Acquir Immune Defic Syndr
|
2009
|
1.31
|
|
4
|
Tuberculosis immune reconstitution inflammatory syndrome in A5221 STRIDE: timing, severity, and implications for HIV-TB programs.
|
J Acquir Immune Defic Syndr
|
2014
|
1.14
|
|
5
|
Prior illicit drug use and missed prenatal vitamins predict nonadherence to antiretroviral therapy in pregnancy: adherence analysis A5084.
|
AIDS Patient Care STDS
|
2008
|
1.03
|
|
6
|
Sustained long-term antiviral maintenance therapy in HCV/HIV-coinfected patients (SLAM-C).
|
J Acquir Immune Defic Syndr
|
2010
|
0.97
|
|
7
|
Predictors of antiretroviral-related hepatotoxicity in the adult AIDS Clinical Trial Group (1989-1999).
|
J Acquir Immune Defic Syndr
|
2006
|
0.92
|
|
8
|
Hepatitis C virus/HIV coinfection and responses to initial antiretroviral treatment.
|
AIDS
|
2013
|
0.87
|
|
9
|
Extended therapy with pegylated interferon and weight-based ribavirin for HCV-HIV coinfected patients.
|
HIV Clin Trials
|
2012
|
0.86
|
|
10
|
Impact of peginterferon alpha and ribavirin treatment on lipid profiles and insulin resistance in Hepatitis C virus/HIV-coinfected persons: the AIDS Clinical Trials Group A5178 Study.
|
Clin Infect Dis
|
2012
|
0.83
|
|
11
|
A reduced frequency visit schedule underreports adverse events that resulted in dose modifications or treatment discontinuations in HIV/AIDS clinical trials: ACTG DACS 207.
|
Contemp Clin Trials
|
2006
|
0.81
|
|
12
|
Clinical, microbiological, and immunological characteristics in HIV-infected subjects at risk for disseminated Mycobacterium avium complex disease: an AACTG study.
|
AIDS Res Hum Retroviruses
|
2005
|
0.76
|